Real-time enrollment status for this atypical hemolytic uremic syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT04889430 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Atypical Hemolytic Uremic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT04889430 is currently active_not_recruiting participants. This clinical trial study for atypical hemolytic uremic syndrome is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04889430 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04889430 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.